These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3586827

  • 1. [Summary of a new assessment strategy in positive occult blood tests in mass screening].
    Robra BP.
    Leber Magen Darm; 1987 Apr; 17(2):113-24. PubMed ID: 3586827
    [Abstract] [Full Text] [Related]

  • 2. Colorectal cancer screening: new opportunities.
    Levin TR.
    Surg Oncol Clin N Am; 1999 Oct; 8(4):673-91, vi-vii. PubMed ID: 10452934
    [Abstract] [Full Text] [Related]

  • 3. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
    Fujita M, Taguchi T, Nakano Y, Oota J, Kimoto Y, Kumanishi Y, Oomichi M, Usugane M, Ueda N, Tsukahara Y.
    Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
    [Abstract] [Full Text] [Related]

  • 4. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
    Manus B, Brägelmann R, Armbrecht U, Stolte M, Stockbrügger RW.
    Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
    [Abstract] [Full Text] [Related]

  • 5. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [Abstract] [Full Text] [Related]

  • 6. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
    Fujita M, Nakano Y, Ohta J, Kumanishi Y, Taguchi T.
    Cancer Detect Prev; 1987 Jul; 10(5-6):353-60. PubMed ID: 3568034
    [Abstract] [Full Text] [Related]

  • 7. Occult-blood screening for colorectal carcinoma: the risks.
    Frank JW.
    Am J Prev Med; 1985 Jul; 1(4):25-32. PubMed ID: 3870908
    [Abstract] [Full Text] [Related]

  • 8. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y.
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [Abstract] [Full Text] [Related]

  • 9. Inappropriate colorectal cancer screening: findings and implications.
    Fisher DA, Judd L, Sanford NS.
    Am J Gastroenterol; 2005 Nov; 100(11):2526-30. PubMed ID: 16279910
    [Abstract] [Full Text] [Related]

  • 10. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS.
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [Abstract] [Full Text] [Related]

  • 11. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L, Paszat LF.
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [Abstract] [Full Text] [Related]

  • 12. [The status of colon cancer screening].
    Fujiyoshi T.
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2223-31. PubMed ID: 1929442
    [Abstract] [Full Text] [Related]

  • 13. [An applied study on the method of multi-factorial quantitative-risk assessment (MFQRA) for mass screening of colorectal cancer].
    Chen K.
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):37-40. PubMed ID: 8334938
    [Abstract] [Full Text] [Related]

  • 14. Occult-blood screening for colorectal carcinoma: the benefits.
    Frank JW.
    Am J Prev Med; 1985 Jan; 1(3):3-9. PubMed ID: 3916713
    [Abstract] [Full Text] [Related]

  • 15. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.
    J Natl Cancer Inst; 2007 Oct 03; 99(19):1462-70. PubMed ID: 17895475
    [Abstract] [Full Text] [Related]

  • 16. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 1: Positive predictive value of occult blood testing].
    Schellenberger U, Raabe A, Erler K.
    Z Arztl Fortbild (Jena); 1987 Oct 03; 81(19):1007-9. PubMed ID: 3439213
    [No Abstract] [Full Text] [Related]

  • 17. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL, Smith A, Bampton PA, Cole SR, Young GP.
    Eur J Gastroenterol Hepatol; 2006 Oct 03; 18(10):1079-83. PubMed ID: 16957514
    [Abstract] [Full Text] [Related]

  • 18. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK, Corder FA, Fancher J, Howden CW.
    Am J Gastroenterol; 2000 Dec 03; 95(12):3629-32. PubMed ID: 11151904
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.
    Wahrendorf J, Robra BP, Wiebelt H, Oberhausen R, Weiland M, Dhom G.
    Eur J Cancer Prev; 1993 May 03; 2(3):221-7. PubMed ID: 8490540
    [Abstract] [Full Text] [Related]

  • 20. [The crypto-hem test in screening for colon cancer].
    Prokorov VV, Shabarov VL.
    Vopr Onkol; 1988 May 03; 34(3):335-8. PubMed ID: 3358298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.